Q1 2025 Management View CEO John Houston highlighted the company's progress in advancing Vepdegestrant (VEPDEG), noting it recently achieved positive pivotal data from the VERITAC-2 study in ESR1 ...

Durham-based restor3d, a developer of three-dimensional printed implants for orthopedic use, has raised $38 million in venture capital. The funding was raised from existing and new private investors, ...